Actively Recruiting
Transdiagnostic Cognitive Biomarkers
Led by University of Minnesota · Updated on 2026-03-04
45
Participants Needed
1
Research Sites
255 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.
CONDITIONS
Official Title
Transdiagnostic Cognitive Biomarkers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have access to the online study platform.
- Age 18 years or older.
- Diagnosis of pain or depression for disease groups.
You will not qualify if you...
- Younger than 18 years.
- Non-English speaking.
- Pregnant women.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
Research Team
D
David Darrow
CONTACT
M
MATTHEW D Maple
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here